Fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis (FEDORA): study protocol for a multicentre, open-label, Bayesian phase II trial.
Saved in:
| Title: | Fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis (FEDORA): study protocol for a multicentre, open-label, Bayesian phase II trial. |
|---|---|
| Authors: | McIlroy, Graham1 (AUTHOR) g.w.mcilroy.1@bham.ac.uk, Gaskell, Charlotte1 (AUTHOR), Jackson, Aimee1 (AUTHOR), Yafai, Emily1 (AUTHOR), Tasker, Rachel1 (AUTHOR), Thomas, Catherine1 (AUTHOR), Fox, Sonia1 (AUTHOR), Boucher, Rebecca1 (AUTHOR), Ghebretinsea, Fitsum1 (AUTHOR), Harrison, Claire2 (AUTHOR), Mead, Adam J.3 (AUTHOR), McMullin, Mary Frances4 (AUTHOR) |
| Source: | BMC Cancer. 1/9/2025, Vol. 25 Issue 1, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14712407 |
|---|---|
| DOI: | 10.1186/s12885-024-13383-3 |
